Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 6Phase 1/2 1

Status

Completed 32Terminated 10Recruiting 6Unknown 4Active not recruiting 2

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 1CNS 1Breast 1

Conditions

Multiple Myeloma 2Recurrence 1Oligodendroglioma 1Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Carcinoma, Intraductal, Noninfiltrating 1Brain Neoplasms 1

Interventions

Cyclophosphamide 118pembrolizumab 104Specimen Handling 104Magnetic Resonance Spectroscopy 94fludarabine 92Biopsy 77Injections 53Nivolumab 43Bevacizumab 41Fluorouracil 38venetoclax 37Cisplatin 36Paclitaxel 35Carboplatin 35Cetuximab 34Radiotherapy 31Oxaliplatin 30fludarabine phosphate 29Leucovorin 28Gemcitabine 28Drug Therapy 25Ipilimumab 23Immunotherapy, Adoptive 23Azacitidine 23Radiation 21Irinotecan 21Temozolomide 20Doxorubicin 20tislelizumab 19atezolizumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting
12 enrolled
CNS

Brain Neoplasms, Oligodendroglioma

NCT07377435 2026-05-08

DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM

Beth Israel Deaconess Medical Center

Phase 1 Recruiting
25 enrolled
Plasma cell

Multiple Myeloma

NCT06799026 2026-05-07

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

Beth Israel Deaconess Medical Center

Phase 1 Recruiting
25 enrolled
Plasma cell

Multiple Myeloma

NCT07374029 2026-05-05

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Beth Israel Deaconess Medical Center

Phase 1 Recruiting
30 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05544968 2026-04-03

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

Medical College of Wisconsin

Phase 1 Recruiting
42 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Neoplasms, Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT04144023 2026-03-05

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Mayo Clinic

Phase 1 Recruiting
43 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡